Caisse De Depot Et Placement Du Quebec Regeneron Pharmaceuticals, Inc. Transaction History
Caisse De Depot Et Placement Du Quebec
- $53.5 Billion
- Q3 2025
A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 462,502 shares of REGN stock, worth $321 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
462,502
Previous 214,722
115.4%
Holding current value
$321 Million
Previous $113 Million
130.69%
% of portfolio
0.49%
Previous 0.25%
Shares
33 transactions
Others Institutions Holding REGN
# of Institutions
1,466Shares Held
86.5MCall Options Held
2.38MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...